Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hongcao Zhihan Granules
- Development stage
- Preclinical
- Lead developer
- Monyan Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Hongcao Zhihan Granules (红草止鼾颗粒) is a Traditional Chinese Medicine (TCM) product developed by Hubei Mengyang Pharmaceutical. It is currently categorized as a Class 2.3 TCM in China, which refers to the development of new therapeutic indications for a previously marketed TCM formulation. While the product's name 'Zhihan' (literally meaning 'stop snoring') reflects its established use in treating sleep-related breathing disorders such as obstructive sleep apnea, Hubei Mengyang is advancing the granule formulation for the treatment of Chronic Obstructive Pulmonary Disease (COPD) and the prevention of acute altitude sickness. The formulation is derived from botanical extracts, likely including *Rhodiola* (Hongjingtian), which is traditionally used to improve oxygen utilization and combat hypoxia. The program is currently in the IND-enabling phase for these new indications.
- Brand names
- 红草止鼾颗粒
- Other names
- Hongcao Zhihan Keli
Beyond the preview
Go deeper on Hongcao Zhihan Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hongcao Zhihan Granules.